| MyShop

Telix to Host Capital Markets Day in Melbourne on November 4, 2026

Image File

Original HTML

Telix to Host Capital Markets Day in Melbourne on November 4, 2026

Melbourne (Australia) and Indianapolis, IN (United States) | October 9, 2026

Telix today advises that it will host a Capital Markets Day in Melbourne, Australia, on Wednesday, November 4, 2026, from 9:00 a.m. to 12:30 p.m. (AEDT).

Institutional investors and analysts are invited to attend the in-person event, which will provide an update on Telix’s commercial portfolio, late-stage pipeline and strategic growth opportunities. Members of the Telix leadership team will present at the event, which will also feature key opinion leaders who will provide their perspectives on Telix’s theranostic programs.

Advance registration is required for in-person attendance. To register your interest please contact charlene.jaw@telixpharma.com or annie.kasparian@telixpharma.com.

The event will be webcast live and available via the Investor Relations section of the Telix website.

Class (B2B/B2C)

Ignore

Ingest Status

Rejected

Dedupe hash

5e651355b0c61bae7f76afcbed266ed2

Press Eligible

Press Eligible Reason

Text too short (149 words. Min: 150)

Source Name

Telix Pharmaceuticals Limited

Original Summary

Telix today advises that it will host advises that it will host a Capital Markets Day in Melbourne, Australia, on Wednesday, November 4, 2026, from 9:00 a.m. to 12:30 p.m. (AEDT). 
The post <a href="https://telixpharma.com/news-views/telix-to-host-capital-markets-day-in… to Host Capital Markets Day in Melbourne on November 4, 2026</a> appeared first on <a href="https://telixpharma.com">Telix Pharmaceuticals Limited</a>.

Original Link

Original Source

Image URL

https://telixpharma.com/wp-content/uploads/2026/10/CMD-tile.png

Source Node

Telix Pharmaceuticals Limited

Content Hash (SHA-256, erste 32 hex)

59bd03879cbd545d128e38b059b8cfba

Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM

Original HTML

Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM

Melbourne (Australia) and Indianapolis, IN (United States) | October 14, 2026

Telix today announces that 20 company-related abstracts will be presented at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in Vienna, Austria from October 17-21, 2026.

Dr. David N. Cade, Telix Group Chief Medical Officer, said, “Our expansive presence at EANM reflects the breadth and maturity of Telix’s pipeline, spanning pivotal therapeutic studies, precision diagnostics and next-generation technologies. The selection of 12 abstracts for top-rated oral presentations is a strong recognition of the quality and clinical relevance of this work. We look forward to continuing this discussion at our sponsored symposium on the future of theranostics in urologic oncology.”

Key presentations include the Phase 3 IPAX BrIGHT trial of TLX101-Tx in recurrent glioblastoma, the Phase 3 LUTEON trial of TLX250-Tx in ccRCC, and interim results from the PTherpan-Lu trial of TLX597-Tx in mAPMR prostate cancer[1]. Topline Phase 3 data for TLX591-Px (Illuccix) PET[2] imaging of prostate cancer in Chinese men will also be presented, together with real-world experience with TLX250-Px (Zircaix[3]) in ccRCC, and research from our targeted alpha therapy and MedTech programs. As in previous years, Telix will support the EANM Sanjiv Sam Gambhir Young Investigator Award, in memory of an extraordinary man and inspiring educator.

Visit booth #527 to explore opportunities for collaboration with Illuccix® (kit for the preparation of gallium-68 gozetotide injection), Telix’s commercial PSMA-PET imaging[4] agent in Europe; our theranostic pipeline; and our medical technologies, including the SENSEI® miniature drop-in gamma probe, QDOSE® dosimetry software and artificial intelligence (AI).

EANM presentation details are as follows (all times CEST):

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

Original HTML

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

Melbourne (Australia), Louvain-la-Neuve (Belgium), Paris (France) and Indianapolis, IN (U.S.) | October 19, 2026

• Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy (TAT).

• Secures long-term, priority isotope access for Telix’s alpha therapy pipeline, including its TLX102-Tx candidate for glioblastoma and leptomeningeal disease, while also supporting third-party academic and industry programs.

• First IBA alpha-beam cyclotron to be installed and operated at Telix’s RLS Radiopharmacies site near Philadelphia, PA.

• Leverages Telix’s vertically integrated U.S. manufacturing and distribution platform, with a framework providing for the parties to evaluate additional installations at RLS sites as demand for 211At develops.

Telix and Ekalia, a joint venture between IBA (Ion Beam Applications S.A., EURONEXT) and Framatome, today announced a collaboration to advance scalable United States (U.S.) production of astatine-211 (211At), an alpha-emitting radioisotope being investigated for targeted alpha therapy.

The collaboration brings together IBA’s specialized alpha-beam cyclotron technology, Framatome’s nuclear and isotope production expertise, and Telix’s U.S. radiopharmacy and “last-mile” infrastructure, clinical portfolio and radiopharmaceutical development capabilities. The alliance expands into the U.S. the strategic partnership formed by IBA and Framatome in Europe to advance industrial-scale ²¹¹At production. The first installation at RLS Trevose is intended to establish a reproducible production model, with the potential for further rollout across the RLS network as demand develops.

Astatine-211 is recognized as a promising alpha-emitting radioisotope for the development of innovative cancer treatments[1]. However, its broader adoption remains constrained by the availability of sufficient production capacity[2]. The collaboration is intended to improve robust, reliable, and timely access to 211At for research and clinical development through a network of production sites in close proximity to clinical centers, helping to further establish theranostics as a cornerstone of precision oncology.

For Telix, the collaboration is expected to support the development of several early-stage therapeutic candidates, including TLX102-Tx (211At astato-L-phenylalanine), a TAT being evaluated for glioblastoma and leptomeningeal disease, as well as future 211At programs. The collaboration is also intended to provide production capacity for third-party academic and industry programs, helping to expand the U.S. 211At development ecosystem.

Bruno Scutnaire, CEO of Ekalia (company in formation) said: “IBA’s specialized alpha-beam cyclotron technology is designed to enable reliable astatine-211 production at the point of need. Building on our work with Framatome in Europe, Telix’s U.S. infrastructure enables us to move faster towards establishing our first U.S. production unit, while laying the foundations for Ekalia’s broader development in the country.”

Chad Watkins, General Manager, Isotope Strategy at Telix, continued: “Owning the path from isotope to patient is central to our development and commercialization strategy. This collaboration gives Telix a dedicated, long-term source of astatine-211 to advance our alpha therapy pipeline, and demonstrates the strategic value of the RLS platform as a host for next-generation isotope production in the U.S. We are delighted to partner with IBA and Framatome, two global leaders in this field, to help advance reliable, scalable astatine-211 production.”

[1] Lindegren et al. EJNMMI Radioph. and Chem. (2026) 11, 15 doi:10.1186/s41181-026-00428-0

[2] Albertsson P et al; Frontiers in Med (2023),9, 1076210: doi:10.3389/fmed.2022.1076210.

Class (B2B/B2C)

B2B

Ingest Status

Rewritten

Dedupe hash

b86fe6ddfeac70aae10ddd7d2470a547

Press Eligible

Yes

Press Eligible Reason

Manuelle Prüfung nötig. Risiko: MEDIUM. Flags: ['medical']. Stichprobe: False

Source Name

Telix Pharmaceuticals Limited

Original Summary

Telix and Ekalia, a joint venture between IBA (Ion Beam Applications S.A., EURONEXT) and Framatome, today announced a collaboration to advance scalable United States (U.S.) production of astatine-211 (211At), an alpha-emitting radioisotope being investigated for targeted alpha therapy.
The post <a href="https://telixpharma.com/news-views/telix-and-ekalia-to-collaborate-on-a… and Ekalia to Collaborate on Astatine-211 Production in the U.S.</a> appeared first on <a href="https://telixpharma.com">Telix Pharmaceuticals Limited</a>.

Original Link

Original Source

Image URL

https://telixpharma.com/default-meta-image.jpg

Source Node

Telix Pharmaceuticals Limited

Content Hash (SHA-256, erste 32 hex)

e79108c9fcee8d075d1452cd01cf2ab1

OPEC Under Threat: UAE Exit Could Change Oil Markets Forever

Image File

Original HTML

OPEC Under Threat: UAE Exit Could Change Oil Markets Forever | Watch | Business News | ET Now

Updated Apr 28, 2026 20:35 IST

OPEC Under Threat: UAE Exit Could Change Oil Markets Forever | Watch | Business News | ET NowThe UAE’s reported exit from the OPEC+ alliance has sparked a major debate in global oil markets.Experts like Peter Cardillo say this could be the first sign of cracks within OPEC, raising questions about the cartel’s long-term future.Meanwhile, energy expert Narendra Taneja believes a weaker OPEC may actually benefit India, allowing for better bilateral oil deals.Key questions:Will oil prices fall if OPEC weakens?Is this the beginning of the end for oil cartels?What does this mean for India, the world’s fastest-growing oil demand center?Watch this detailed discussion to understand the global oil market shift.#opec #uae #oilprices #crudeoil #energymarket #indiaeconomy #globalmarkets #oilnews #geopolitics #businessnews #etnow #energycrisis #opecplus #marketupdate #oiltrade

Class (B2B/B2C)

B2B

Ingest Status

Rewritten

Dedupe hash

5e18efde9bc14956e923d1c608f7c2b6

Press Eligible

Yes

Press Eligible Reason

Covers OPEC and the potential impact of the UAE’s exit on global oil markets and energy trade.

Source Name

Spartan Capital Securities, LLC

Original Summary

OPEC Under Threat: UAE Exit Could Change Oil Markets Forever | Watch | Business News | ET NowThe UAE’s reported exit from the OPEC+ alliance has […]
The post <a href="https://www.etnownews.com/videos/opec-under-threat-uae-exit-could-chang… Under Threat: UAE Exit Could Change Oil Markets Forever</a> appeared first on <a href="https://spartancapital.com">Spartan Capital Securities</a>.

Original Link

Original Source

Image URL

https://images.etnownews.com/thumb/msid-154190586,thumbsize-1017962,width-1280,height-720,resizemode-75/154190586.jpg

Source Node

Spartan Capital Securities, LLC

Content Hash (SHA-256, erste 32 hex)

366e26061b46f2720bef36ea524383fe

Linea Mercati Interview 4/28/26

Image File

Original HTML

OPEC Under Threat: UAE Exit Could Change Oil Markets Forever

April 28, 2026

Linea Mercati Interview 4/29/26

April 30, 2026

Alternus Clean Energy is a forward-thinking utility-scale clean energy independent power producer that effectively leverages transatlantic markets to amplify its impact and create value for shareholders. With a strategic focus on solar, battery storage and microgrids, Alternus has a robust portfolio and pipeline featuring operational and projects in development across America and Europe, backed by long-term power purchase agreements that ensure stable revenue streams.

Founded in 2015, Perfect Corp. is a beautiful AI Company and global leader in enterprise SaaS solutions. As an innovative powerhouse in using artificial intelligence (AI) to transform the beauty and fashion industries, Perfect empowers major beauty, skincare, fashion, jewelry brands and retailers by providing consumers with omnichannel shopping experiences through augmented reality (AR) product try-ons and AI-powered skin diagnostics. With cutting-edge technologies such as Generative AI, real-time facial and hand 3D AR rendering and cloud solutions, Perfect enables personalized, enjoyable, and engaging shopping journey.

In addition, Perfect also operates a family of YouCam consumer apps for photo, video and camera users, centered on unleashing creativity with AI-driven features for creation, beautification and enhancement. With the help of technologies, Perfect helps brands elevate customer engagement, increase conversion rates, and propel sales growth. Throughout this journey, Perfect maintains its unwavering commitment to environmental sustainability and fulfilling social responsibilities. For more information, visit https://ir.perfectcorp.com/.

Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. The Company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram-positive specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE) and drug-resistant Streptococcus pneumoniae (DRSP). To learn more about Acurx Pharmaceuticals and its product pipeline, please visit www.acurxpharma.com

Founded in 2010, AgEagle was originally formed to pioneer proprietary, professional-grade, fixed-winged drones and aerial imagery-based data collection and analytics solutions for the agriculture industry. Today, the Company is earning distinction as a globally respected market leader offering customer-centric, advanced, autonomous unmanned aerial systems ("UAS”) which drive revenue at the intersection of flight hardware, sensors and software for industries that include agriculture, military/defense, public safety, surveying/mapping and utilities/engineering, among others. AgEagle has also achieved numerous regulatory firsts, including earning governmental approvals for its commercial and tactical drones to fly Beyond Visual Line of Sight ("BVLOS”)and/or Operations Over People ("OOP”) in the United States, Canada, Braziland the European Union and being awarded Blue UAS certification from the Defense Innovation Unit of the U.S. Department of Defense.

BREAKTHROUGH ARTIFICIAL INTELLIGENCE. Our proprietary AI-technology will transform education by delivering dynamic, real-time and two-way human-like conversations with our AI-Super Teachers.

AI-POWERED SUPER TEACHERS: Imagine having a teacher available 24/7 who adapts to your learning style and offers instant feedback. Our AI-powered teachers make this into reality. Our algorithms and natural language processing provide personalized lessons, conversations, and offer real-time feedback to enrich your learning experience.

COMBINING PROFESSIONAL AND LANGUAGE SKILLS LEARNING; Professional skills and topics covered include hospitality, nursing, engineering, AI coding, computer science, social media marketing, high school exam prep, and much more.

CUSTOMIZED LEARNING PATHS AI algorithms analyze a learner's proficiency, learning style, strengths, weaknesses, and goals to create a tailor-made learning path. This ensures that the content is relevant to the individual.

A UNIQUE AI-POWERED EVALUATION SYSTEM This simulates real-life scenarios to provide the most meaningful performance assessment and proof of ability.

FROM A FINANCIAL PERSPECTIVE, THE POTENTIAL IS ENORMOUS Our platform meets specific training needs for career development across multiple industries, ensuring lucrative engagement and robust ROI. Sectors like coding and hospitality alone present giant market opportunities.

ALPHA COGNITION, INC is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative disease, such as Alzheimer’s disease and Cognitive Impairment with mild Tramautic Brain Injury (“mTBI”). The Company’s first product ZUNVEYL is approved by the U.S. Food and Drug Administration (FDA) as a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults.

Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "

ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US$1.2 billion in cryptocurrency transactions in 2023. ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.

ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.

CEL-SCI Corporation (NYSE American: CVM) is a biotechnology company that believes that boosting a cancer patient’s immune system before surgery, radiotherapy and chemotherapy, while it is still intact, should provide the greatest possible impact on survival.

Chromocell is a pioneer in the development of non-opioid pain treatment therapeutics with a focus on modulating NaV1.7 receptors responsible for sensing and transmitting pain in the peripheral nervous system. The Company’s programs targeting the treatment of chronic neuropathic and acute and chronic eye pain are based on its patented core molecules.

Focus Universal Inc. (NASDAQ:FCUV) is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 28 patents and patents pending in various phases and 8 trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Markets.

Greenland Technologies Holding Corp (NASDAQ: GTEC) is a leading developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling vehicles.

Impact Biomedical Inc.(IBIO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships.

By leveraging technology and new science with strategic partnerships, we provide advances in biopharmaceuticals, over the counter direct to consumer wellness offerings, and drug discovery for the prevention, inhibition, and treatment of neurological, oncologic, and inflammatory diseases. In addition to our existing efforts, we continually search for, and evaluate, other potential new offerings to add to our portfolio.

Our business model includes partnering and potentially direct sales for commercialization and distribution. Potential licensors and development partners include pharmaceutical, consumer packaged goods companies and others, who would commercialize IBIO technologies in exchange for milestone, and royalty payments.

Lipella Pharmaceuticals (Nasdaq: LIPO) is a Pittsburgh-based clinical-stage biotechnology company focused on developing treatments for serious diseases with significant unmet needs. The company has a broad portfolio of three promising IND-approved assets and operates an in-house manufacturing facility. Lipella’s proprietary drug delivery platform utilizes liposomal formulations of tacrolimus, enabling localized treatment with minimal systemic exposure. The company is advancing two lead assets in Phase 2 clinical trials: LP-10, targeting hemorrhagic cystitis, and LP-310, an oral rinse for Oral Lichen Planus. Both programs leverage the 505(b)(2) regulatory pathway to expedite development and reduce costs.

Ingest Status

Rejected

Dedupe hash

e4873dedfb493fc3d628a3a724157215

Source Name

Spartan Capital Securities, LLC

Original Summary

The post <a href="https://spartancapital.com/linea-mercati-interview-4-28-26/">Linea Mercati Interview 4/28/26</a> appeared first on <a href="https://spartancapital.com">Spartan Capital Securities</a>.

Original Link

Original Source

Image URL

https://spartancapital.com/wp-content/uploads/2025/09/Linea-Mercati.jpg

Source Node

Spartan Capital Securities, LLC

Content Hash (SHA-256, erste 32 hex)

75831cb68645c8a421eeeba2df7af4ef

Linea Mercati Interview 4/29/26

Image File

Original HTML

Linea Mercati Interview 4/28/26

April 29, 2026

VIEW US growth picks up; PCE inflation is higher but in line with expectations

April 30, 2026

BREAKTHROUGH ARTIFICIAL INTELLIGENCE. Our proprietary AI-technology will transform education by delivering dynamic, real-time and two-way human-like conversations with our AI-Super Teachers.

A UNIQUE AI-POWERED EVALUATION SYSTEM This simulates real-life scenarios to provide the most meaningful performance assessment and proof of ability.

Greenland Technologies Holding Corp (NASDAQ: GTEC) is a leading developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling vehicles.

Ingest Status

Rejected

Dedupe hash

23fdc3f365d5b50c8fccacf181c1ee10

Source Name

Spartan Capital Securities, LLC

Original Summary

The post <a href="https://spartancapital.com/linea-mercati-interview-4-29-26/">Linea Mercati Interview 4/29/26</a> appeared first on <a href="https://spartancapital.com">Spartan Capital Securities</a>.

Original Link

Original Source

Image URL

https://spartancapital.com/wp-content/uploads/2025/09/Linea-Mercati.jpg

Source Node

Spartan Capital Securities, LLC

Content Hash (SHA-256, erste 32 hex)

b661f5c92c1dd20d6a2935c7845e54c3

VIEW US growth picks up; PCE inflation is higher but in line with expectations

Image File

Original HTML

Linea Mercati Interview 4/29/26

April 30, 2026

US Accuses Mexican Governor Moya Of Cartel Conspiracy, Sheinbaum Demands Evidence

April 30, 2026

By Reuters

April 30, 20269:30 AM EDTUpdated 8 mins ago

People walk through a shopping mall at The Venetian Las Vegas resort, in Las Vegas, Nevada, U.S., November 18, 2025. REUTERS/Daniel Cole/File Photo Purchase Licensing Rights, opens new tab

NEW YORK, April 30 (Reuters) – U.S. economic growth picked up in the first quarter on a rebound in government spending, but the increase is likely temporary as the drives up gasoline prices and squeezes household budgets.

Gross domestic product increased at a 2.0% annualized rate last quarter, the Commerce Department’s Bureau of Economic Analysis said in its advance GDP estimate on Thursday. Economists polled by Reuters had forecast GDP growth increasing at a 2.3% annualized rate. Much of the growth came from a partial reversal in government outlays.

Get a look at the day ahead in U.S. and global markets with the Morning Bid U.S. newsletter. Sign up here.

Advertisement · Scroll to continue

Meanwhile the U.S. Commerce Department said on Thursday its Personal Consumption Expenditures Price Index (PCE) rose in line with expectations in March, the latest sign that inflation remained relatively well behaved despite the war with Iran. March PCE rose 3.5% year over year, matching the consensus estimate, while rising 0.7% from February, also matching estimates. The core PCE price index, excluding volatile food and energy prices, rose 0.3% as expected.

MARKET REACTION:

STOCKS: U.S. major indexes were set to open higher, with futures tracking the Dow Jones Industrial Average (.DJI), opens new tab up 0.7%.

BONDS: Treasury securities rallied on Thursday morning, with the yields on the 2-year and 10-year Treasury notes falling. The 2-year note was down 6 basis points to 3.89% and the 10-year note was off 3 basis points to 4.38%.

Advertisement · Scroll to continue

FOREX: The dollar index was off 0.4% to 98.50.

COMMENTS:

PETER CARDILLO, CHIEF MARKET ECONOMIST, SPARTAN CAPITAL SECURITIES, NEW YORK:

“Well, 2.0% GDP was a rebound from the low growth rate in Q4, which was mostly due to the government shutdown. The first quarter suggests that we’re probably going to average 2.5% for the year, is solid growth, but certainly nothing that you can describe as extreme. It’s basically the average GDP growth that we’ve had for the past four to five years.

“Personal spending came in better than expected, and it shows that the consumer remains resilient. That’s subject to change, of course, if energy prices continue to rise.

“Headline and core year-on-year inflation above 3.2% is obviously a negative. And most of it, of course, is due to energy prices. For now, we can label it as transitory. However, if the war continues and energy prices do not come down from the present levels, that transitory inflation will become constant inflation and certainly a major headache for the Federal Reserve.”

MICHAEL LORIZIO, HEAD OF US RATES AND MORTGAGE TRADING AT MANULIFE INVESTMENT MANAGEMENT, BOSTON;

“The U.S. data this morning was mixed but probably validates the Fed’s stance yesterday of a little bit of a hawkish turn or a hawkish leaning compared to the previous meeting. I would not be leaning into any of the communication that a hike is in anyone’s immediate forecast, but some more balanced view and more just a commitment to looking at how the economic data comes in from here on out.

“Today was a big first step in that and seeing how measured inflation from their preferred measure looks and core PCE obviously being as expected, but materially higher than where the Fed would like to see it. It was already materially higher pre the conflict in Iran and this is just accelerating that.”

“On the flip side, jobless claims hitting such low levels and continuing claims hitting low levels… there’s reason for the Fed to continue to have concerns there, and this doesn’t take that away, but there’s no ammunition here for the Fed to continue to talk about near-term cuts. And that I think was the purpose of their change in messaging yesterday, or the dissenters’ push for a broader change in messaging.”

BRIAN JACOBSEN, CHIEF ECONOMIST, ANNEX WEALTH MANAGEMENT, MENOMONEE FALLS, WISCONSIN:

“High growth isn’t always healthy growth. Half a percentage point of GDP growth came from computers and another half from healthcare. It’s not a shaky foundation for growth, but not the most solid either.”

Reporting by Stephen Culp, Karen Brettell and Chuck Mikolajczak; editing by Colin Barr

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Class (B2B/B2C)

B2B

Ingest Status

Rewritten

Dedupe hash

7ac5541fc821048336c1776412cf8842

Press Eligible

Yes

Press Eligible Reason

Manuelle Prüfung nötig. Risiko: HIGH. Flags: ['finance', 'numbers']. Stichprobe: False

Source Name

Spartan Capital Securities, LLC

Original Summary

By Reuters April 30, 20269:30 AM EDTUpdated 8 mins ago People walk through a shopping mall at The Venetian Las Vegas resort, in Las Vegas, Nevada, U.S., […]
The post <a href="https://spartancapital.com/view-us-growth-picks-up-pce-inflation-is-hig… US growth picks up; PCE inflation is higher but in line with expectations</a> appeared first on <a href="https://spartancapital.com">Spartan Capital Securities</a>.

Original Link

Original Source

Image URL

https://spartancapital.com/wp-content/uploads/2020/07/reuters-logo.jpg

Source Node

Spartan Capital Securities, LLC

Content Hash (SHA-256, erste 32 hex)

d8b8f5b131744368452c500bd54e9e36

S&P 500, Nasdaq set for biggest monthly gains since 2020

Image File

Original HTML

US Accuses Mexican Governor Moya Of Cartel Conspiracy, Sheinbaum Demands Evidence

April 30, 2026

Bond yields fall, stocks rise as oil prices fall; yen jumps after Japan’s reported currency intervention

April 30, 2026

By Stephen Culp and Niket Nishant

April 30, 20265:26 AM EDTUpdated 37 mins ago

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 29, 2026. REUTERS/Brendan McDermid Purchase Licensing Rights, opens new tab

- Summary

- Companies

- Indexes up: Dow 1.51%, S&P 500 0.89% and Nasdaq 0.83%

- Alphabet rises after strong results

- Meta, Microsoft fall on capex concerns

- Eli Lilly gains after lifting forecast

NEW YORK, April 30 (Reuters) – U.S. stocks advanced on Thursday and the S&P 500 and the Nasdaq headed for their biggest monthly gains in years as solid corporate earnings helped investors look past a war-related oil supply shock that has rattled markets and sent crude prices to four-year highs.

But oil prices , eased as investors prepared to close the book on April with solid gains. The S&P 500 and the Nasdaq were on course for their biggest monthly percentage gains since the Covid crash recovery in 2020.

Industrials (.SPLRCI), opens new tab, powered by Caterpillar shares, put the Dow out front, while technology contained the Nasdaq’s gains in the wake of a spate of high-profile quarterly results released late Wednesday.

Four members of the Magnificent Seven group of artificial intelligence-related megacaps reported late Wednesday: Alphabet (GOOGL.O), opens new tab, Amazon (AMZN.O), opens new tab, Meta Platforms (META.O), opens new tab and Microsoft (MSFT.O), opens new tab. Of those, only Alphabet shares were in positive territory, jumping 9.7% after reporting a record quarter for its cloud unit.

Amazon was off 0.4%, while Meta and Microsoft slid 7.8% and 4.7%, respectively, on concerns over artificial intelligence-related expenditures.

Apple (AAPL.O), opens new tab, another Magnificent Seven constituent, was slated to report after the bell.

The Dow Jones Industrial Average (.DJI), opens new tab rose 738.90 points, or 1.51%, to 49,600.71, the S&P 500 (.SPX), opens new tab gained 63.31 points, or 0.89%, to 7,199.26 and the Nasdaq Composite (.IXIC), opens new tab gained 204.35 points, or 0.83%, to 24,878.32.

Of the 11 major sectors in the S&P 500, only technology (.SPLRCT), opens new tab was red, while communication services (.SPLRCL), opens new tab and industrials (.SPLRCI), opens new tab led the gainers.

CRUDE PRICES, INFLATION AND THE FED

A raft of economic data showed the U.S. economy grew by 2.0% in the first three months of 2026, while initial jobless claims dipped to their lowest since 1969 and soaring energy prices kept year-on-year inflation above 3%, thwarting hopes of near-term rate cuts from the Federal Reserve as Jerome Powell’s eight-year tenure as chair draws to a close.

“For now, we can label (inflation) as transitory,” said Peter Cardillo, chief market economist at Spartan Capital Securities in New York. “However, if the war continues and energy prices do not come down from the present levels, that transitory inflation will become constant inflation and certainly a major headache for the Federal Reserve.”

On Wednesday, in its most divided vote since 1992, the central bank let its key interest rate stand, while acknowledging uncertainties related to heightened crude prices due to the conflict in the Middle East.

That conflict showed no sign of abating, with Iran warning of retribution if the United States abandons its ceasefire and renews its attacks, suggesting that efforts to negotiate a peace deal have hit an impasse. Top U.S. military leaders were expected to brief President Donald Trump on potential military action in Iran, a U.S. official told Reuters.

The possibility of protracted war, long-term disruption of traffic in the Strait of Hormuz, and the prolonged pressure on energy prices have dampened hopes for near-term policy easing from monetary policymakers.

Inflation gauges

Eli Lilly (LLY.N), opens new tab gained 10.3% after the drugmaker raised its annual profit forecast on sustained weight-loss drug demand.

Caterpillar (CAT.N), opens new tab shares rose 10.1%, touching a record high following the company’s reported rise in first-quarter profit due to strong demand for its power generation and construction equipment.

Advancing issues outnumbered decliners by a 3.54-to-1 ratio on the NYSE. There were 281 new highs and 47 new lows on the NYSE.

On the Nasdaq, 3,408 stocks rose and 1,237 fell as advancing issues outnumbered decliners by a 2.76-to-1 ratio.

The S&P 500 posted 29 new 52-week highs and 15 new lows while the Nasdaq Composite recorded 99 new highs and 86 new lows.

Reporting by Niket Nishant and Utkarsh Hathi in Bengaluru; Editing by Devika Syamnath, Shinjini Ganguli and Aurora Ellis

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Class (B2B/B2C)

B2B

Ingest Status

Rewritten

Dedupe hash

21a70c558e0df198f4edfb32c4951726

Press Eligible

Yes

Press Eligible Reason

Manuelle Prüfung nötig. Risiko: HIGH. Flags: ['finance', 'numbers']. Stichprobe: False

Source Name

Spartan Capital Securities, LLC

Original Summary

By Stephen Culp and Niket Nishant April 30, 20265:26 AM EDTUpdated 37 mins ago   Traders work on the floor at the New York Stock Exchange (NYSE) in […]
The post <a href="https://spartancapital.com/sp-500-nasdaq-set-for-biggest-monthly-gains-… 500, Nasdaq set for biggest monthly gains since 2020</a> appeared first on <a href="https://spartancapital.com">Spartan Capital Securities</a>.

Original Link

Original Source

Image URL

https://spartancapital.com/wp-content/uploads/2020/07/reuters-logo.jpg

Source Node

Spartan Capital Securities, LLC

Content Hash (SHA-256, erste 32 hex)

3a37336cb97e4321dfca9e15c5c0a910

Bond yields fall, stocks rise as oil prices fall; yen jumps after Japan’s reported currency intervention

Image File

Original HTML

S&P 500, Nasdaq set for biggest monthly gains since 2020

April 30, 2026

Linea Mercati Interview 4/30/26

May 4, 2026

By Caroline Valetkevitch and Marc Jones

April 29, 20269:56 PM EDTUpdated 1 hour ago

Item 1 of 2 Futures-options traders work on the floor at the New York Stock Exchange’s NYSE American (AMEX) in New York City, U.S., April 17, 2026. REUTERS/Brendan McDermid/File Photo

[1/2]Futures-options traders work on the floor at the New York Stock Exchange’s NYSE American (AMEX) in New York City, U.S., April 17, 2026. REUTERS/Brendan McDermid/File Photo Purchase Licensing Rights, opens new tab

- Summary

- Companies

- Brent tumbles after reaching a four-year high

- ECB and BoE both hold rates in Europe

- Global bond yields drop

- Apple results due later on Thursday on Wall Street

NEW YORK/LONDON, April 30 (Reuters) – Global bond yields fell and major stock indexes gained on Thursday as oil prices retreated from four-year highs, while the yen jumped after Japanese authorities were reported to have intervened in foreign exchange markets to support their currency.

U.S. crude fell 2.02% to $104.72 a barrel and Brent fell to $114.03 per barrel, down 3.39% on the day.

Iran said it would respond with “long and painful strikes” on U.S. positions if Washington renewed attacks, and also reasserted its control over the Strait of Hormuz, complicating U.S. plans for a coalition to reopen the waterway.

ECB and Bank of England kept rates steady. On Wednesday, there was a hawkish shift in tone from the Federal Reserve as it left rates on hold. Three of the U.S. central bank’s board members voted to drop the easing bias in its policy statement in the most divided decision since 1992.

“Yields are moving lower because the price of oil is coming down. That’s helping stocks, as well as some of the earnings reports that were good,” said Peter Cardillo, chief market economist at Spartan Capital Securities in New York.

Tech-related earnings were mostly strong, with shares of Alphabet (GOOGL.O), opens new tab up sharply following a for its cloud unit.

Earnings from iPhone maker Apple (AAPL.O), opens new tab are due after the closing bell.

The S&P 500 and the Nasdaq were on course to end April with their biggest gains since 2020.

The Dow Jones Industrial Average (.DJI), opens new tab rose 669.39 points, or 1.37%, to 49,530.40, the S&P 500 (.SPX), opens new tab rose 30.40 points, or 0.43%, to 7,166.35 and the Nasdaq Composite (.IXIC), opens new tab rose 12.65 points, or 0.05%, to 24,685.40.

MSCI’s gauge of stocks across the globe (.MIWD00000PUS), opens new tab rose 5.36 points, or 0.50%, to 1,072.92. The pan-European STOXX 600 (.STOXX), opens new tab index rose 1.38%.

The U.S. dollar fell sharply against the yen after Japanese authorities were reported to have intervened in foreign exchange markets to support their currency.

Officials had intervened to buy the yen, two sources familiar with the matter told Reuters, after it hit its weakest against the dollar since July 2024.

The dollar fell by as much as 3% against the yen to 155.5 yen, making for the largest single-day drop since late December 2024. It was last down 2.36% at 156.51 yen. Against the Japanese yen , the dollar was last down 2.38% at 156.57.

The yield on benchmark U.S. 10-year notes fell 1.8 basis points to 4.398%, from 4.416% late on Wednesday.

The 2-year UK gilt yields were back below 4.5%, while 2-year German yields – which are sensitive to near-term ECB rate changes – looked set to snap an eight-day run on gains.

The day’s earlier swing in oil prices was over 10 percentage points. Brent was last at $113.5 a barrel and down almost 4% having been as high as $126.41 overnight. It is still nearly double the price it started the year at.

On Wednesday, outgoing Chair Jerome Powell confirmed he would stay on as a governor for now to defend the institution’s independence as his successor Kevin Warsh, picked by low-rate advocate U.S. President Donald Trump, moves toward confirmation.

An arrow chart with the title ‘How interest rates have changed among G10 central banks’

Reporting by Caroline Valetkevitch and Marc Jones; editing by Timothy Heritage and Nick Zieminski

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Class (B2B/B2C)

B2B

Ingest Status

Rewritten

Dedupe hash

1fe57194536ebe4b7c71604b9b44f691

Press Eligible

Yes

Press Eligible Reason

Manuelle Prüfung nötig. Risiko: HIGH. Flags: ['finance', 'numbers']. Stichprobe: False

Source Name

Spartan Capital Securities, LLC

Original Summary

By Caroline Valetkevitch and Marc Jones April 29, 20269:56 PM EDTUpdated 1 hour ago Item 1 of 2 Futures-options traders work on the floor at the New York Stock […]
The post <a href="https://spartancapital.com/bond-yields-fall-stocks-rise-as-oil-prices-f… yields fall, stocks rise as oil prices fall; yen jumps after Japan’s reported currency intervention</a> appeared first on <a href="https://spartancapital.com">Spartan Capital Securities</a>.

Original Link

Original Source

Image URL

https://spartancapital.com/wp-content/uploads/2020/07/reuters-logo.jpg

Source Node

Spartan Capital Securities, LLC

Content Hash (SHA-256, erste 32 hex)

0230afb47ff324d76af5f19b7c283331

Oro a 6.000 dollari entro la fine dell’anno

Image File

Original HTML

BREAKTHROUGH ARTIFICIAL INTELLIGENCE. Our proprietary AI-technology will transform education by delivering dynamic, real-time and two-way human-like conversations with our AI-Super Teachers.

A UNIQUE AI-POWERED EVALUATION SYSTEM This simulates real-life scenarios to provide the most meaningful performance assessment and proof of ability.

Alzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”). Our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43+ Million Americans suffering from these debilitating diseases. Our current pipeline consists of two novel therapeutic drug candidates, AL001 – a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and ALZN002 – a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s. Both of our product candidates are licensed from the University of South Florida Research Foundation, Inc. pursuant to royalty-bearing exclusive worldwide licenses.

Greenland Technologies Holding Corp (NASDAQ: GTEC) is a leading developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling vehicles.

Our business model includes partnering and potentially direct sales for commercialization and distribution.

Ingest Status

New

Dedupe hash

86d674e67a56a052b6f575e4c848b489

Source Name

Spartan Capital Securities, LLC

Original Summary

La Federal Reserve non varia i tassi d’interesse, mentre la Banca Centrale Europea potrebbe alzarli. Ne parliamo in compagnia di Peter Cardillo.
The post <a href="https://spartancapital.com/oro-a-6-000-dollari-entro-la-fine-dellanno/"… a 6.000 dollari entro la fine dell’anno</a> appeared first on <a href="https://spartancapital.com">Spartan Capital Securities</a>.

Original Link

Original Source

Image URL

https://spartancapital.com/wp-content/uploads/2024/11/ucapital-logo.jpg

Source Node

Spartan Capital Securities, LLC

Luna Batch ID

batch_6ad6b2ac60fc819088db9372a775b103

Content Hash (SHA-256, erste 32 hex)

ea51bcc237aeebc2151b515f21871096